Precision Oncology Company 4baseCare Launches One-of-its-kind Indian Population Specific Cancer Gene Panel

  • | Wednesday | 18th August, 2021

4baseCare, a precision oncology company in India, launched their product - TARGT Indiegene, India’s largest and first population-specific tumour gene panel derived from Whole Exome and Whole Transcriptome data of over 1500 cancer patients across 28 different cancer types. For example, the TARGT Indiegene' cancer panel is based on insights generated from tumour tissues of Indian cancer patients resulting in better success rates using precision medicine in the management of cancer. The insights from research have helped build the largest resource of mutational signatures identified in cancer patients in India. Supporting the research and commercialisation initiative are Illumina Accelerator, Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures and a few strategic angel investors. About 4baseCare4baseCare, an Illumina Accelerator Company, is engaged in the development of cutting-edge precision oncology solutions, using advanced genomics and next-gen digital health technology, to personalise patient care in oncology.

Read Full Article Here

If You Like This Story, Support NYOOOZ



Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.

Stay updated with all the Latest Bangalore headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.

Related Articles